๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

โœ Scribed by Aarsland, D. (author);Laake, K. (author);Larsen, J. P. (author);Janvin, C. (author)

Book ID
115470345
Publisher
BMJ Publishing Group
Year
2002
Tongue
English
Weight
328 KB
Volume
72
Category
Article
ISSN
0022-3050

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized placebo-controlled trial of d
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease
โœ Iracema Leroi; Jason Brandt; Stephen G. Reich; Constantine G. Lyketsos; Stephen ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

## Abstract ## Objective To evaluate the efficacy and safety of donepezil, an acetylcholinesterase inhibitor, as a treatment for cognitive impairment and dementia in patients with Parkinson' s disease (PD). ## Methods Using a randomized, doubleโ€blind, placeboโ€controlled design, nine patients rec

Controlled study of decision-making and
Controlled study of decision-making and cognitive impairment in Parkinson's disease
โœ Javier Pagonabarraga; Carmen Garcรญa-Sรกnchez; Gisela Llebaria; Berta Pascual-Seda ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB ๐Ÿ‘ 1 views

## Abstract Impulse control disorders (ICD) related to rewardโ€processing dysfunction have been reported in Parkinson's disease (PD). The relationship between clinical markers of limbic dysfunction with demographic variables and cognitive status of PD is incompletely known. Our objective was to furt